A novel wearable medical device and eHealth system to improve the mobility of patients with hemiparesis

Información del proyecto

MovEAID

Identificador del acuerdo de subvención: 773301

DOI

10.3030/773301

Proyecto cerrado

Fecha de la firma de la CE 12 Mayo 2017

Fecha de inicio 1 Junio 2017

Fecha de finalización 30 Noviembre 2017

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

REMOD UG (HAFTUNGSBESCHRANKT)
Germany

Objetivo

REMOD is a young German SME with 6 employees, specialized in rehabilitation technology and rehabilitative medicine. We deliver innovativ training for chronically ill patients, and develop rehabilitation devices linked to the training content. One in five people experience a stroke at some point in their lives, and half of all strokes lead to paralysis of one side of the body, called hemiparesis. There are around 550,000 hemiparesis cases per year in the EU. Strokes cost the EU about €34.3 billion per year, of which €17 billion is spent on the treatment of hemiparesis. These costs do not include indirect costs due to incapacity to work, or unpaid care provided by relatives and friends. As such, strokes and hemiparesis are of great socioeconomic importance. Since there is no known cure for hemiparesis, treatment focuses on rehabilitation to minimise further loss of body function and reduce pain, muscle regression, or spastic paralysis due to reduced mobility. Existing rehabilitation methods includes: weak dorsiflexion, orthosis, hippotherapy and the use of therapeutic and neurorehabilitation devices. Such rehabilitation accounts for €8 billion per year of direct costs in the EU. Mobility improvements can be made with intense physiotherapy, but these improvements are not lasting due to brain damage which affects movement memory. Currently no solution exists that leads to a lasting improvement in the mobility of hemiparesis patients.
We have developed, patented, and demonstrated (to TRL6) a novel wearable medical device which is embedded into a special vest to correct the posture and movement of patients suffering from hemiparesis and are now miniaturizing the device and developing the MovEAid eHealth system, containing the device and vest, for use by hemiparesis patients and health care professionals. With the help of the SME instrument, we now like to scale up our Minimal Viable Product to TRL9 and aim to bring the initial MovEAid system to the Market in 2020.

Ámbito científico (EuroSciVoc)

• ciencias médicas y de la salud › ciencias de la salud › asistencia sanitaria › sanidad electrónica
• ciencias médicas y de la salud › medicina clínica › fisioterapia
• ciencias sociales › sociología › cuestiones sociales › desigualdad social
• ciencias médicas y de la salud › medicina básica › neurología › accidente cerebrovascular
• ingeniería y tecnología › ingeniería médica › tecnología médica vestible

Programa(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being PROGRAMA PRINCIPAL
  
• H2020-EU.3.1.4. - Active ageing and self-management of health
  
• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
  
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
  
• H2020-EU.3.1.6. - Health care provision and integrated care
  

Tema(s)

• SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
  

Régimen de financiación

SME-1 - SME instrument phase 1

Convocatoria de propuestas

H2020-SMEInst-2016-2017

Coordinador

REMOD UG (HAFTUNGSBESCHRANKT)

• Aportación neta de la UEn: € 50 000,00
• Dirección: REINICKENDORFERSTR. 15 ; 13347 BERLIN ; Alemania
• Pyme Sí:
  Región
  Berlin › Berlin › Berlin
• Región: Berlin › Berlin › Berlin
• Tipo de actividad: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Coste total: € 71 429,00